Organon transferred with a Hold at TD Cowen

TD Cowen analyst Michael Nedelcovych took over primary coverage of Organon (OGN) with a Hold rating and $19 price target Organon presented business updates that provide some insight into the 2025 outlook, but business development may be “muted” until 2026 as the company focuses on its balance sheet, the analyst tells investors.